Arwan Pharmaceutical Industries Lebanon

What Arwan Pharmaceutical Industries Lebanon does

Arwan Pharmaceutical Industries Lebanon s.a.l. is a privately held Lebanese biotech pharmaceutical manufacturer founded in 2009 and headquartered in Jadra, Al Chouf, with a workforce in the 101–250 band. The company's stated mission is to deliver affordable, premium-quality critical care medicines, localize essential-medicine production for the Arab world, and reduce regional reliance on pharmaceutical imports. It manufactures sterile dosage forms — liquid ampoules (2–5 mL), liquid vials (2 mL), and lyophilized vials (15–20 mL) — through aseptic and terminal sterilization processes, and sells critical care medicines across 18 therapeutic categories including cardiovascular, neuropsychiatry, gastroenterology and hepatology, respiratory, antimicrobial therapy, dermatology, hematology, endocrinology and metabolism, pain and inflammation management, anti-migraine, anti-anemia, leukotriene modifiers, proton pump inhibitors, gastrointestinal motility agents, tissue repair and wound healing, oncology, and critical and emergency care.

Arwan's technology base centers on sterile fill-finish and lyophilization capacity combined with in-house analytical capabilities (liquid chromatography, gas chromatography, spectrophotometry, FTIR) and a proprietary Data Matrix laser-printed anti-counterfeit 'fingerprint' traceability system applied to each unit. Quality systems are anchored on GMP compliance and a WHO Prequalification accreditation awarded in February 2020, which made Arwan's Quality Control Laboratory one of 57 such labs worldwide and the only prequalified lab in the Middle East. The company also offers laboratory testing services (assay, dissolution, microbiological, sterility, endotoxin) as a standalone commercial line.

Commercially, Arwan runs a B2B distributor-only model, appointing a single exclusive distributor per country across MENA (Qatar, Oman, Jordan, Iraq, Saudi Arabia, Kuwait, Lebanon, UAE), CIS (Afghanistan, Tajikistan, Turkmenistan, Uzbekistan), and Africa (Botswana, Cameroon, Kenya, Nigeria, Egypt, Libya) — 17 countries in total. Strategic European partnerships provide access to advanced facilities and expertise. The company is founder-controlled: Mr. Abdul Razzak Youssef is Founder and President, Ruwayda Dham is Co-Founder and Vice President, and Dr. Rasha Jouni serves as Technical Director and Deputy General Manager. No external institutional investors, funding rounds, acquisitions, or parent-company relationships are evidenced in the available data.

Name

Arwan Pharmaceutical Industries Lebanon

Legal name

Arwan Pharmaceutical Industries Lebanon s.a.l.

Website

https://arwanlb.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

Arwan Pharmaceutical Industries Lebanon is a Lebanese biotech manufacturer, founded in 2009 and headquartered in Jadra, that develops and distributes sterile critical care medicines across 18 therapeutic areas to 17 countries in MENA, CIS and Africa through exclusive country-level distributors.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Critical care medicines
• Pharmaceutical manufacturing
• Sterile injectables
• Lyophilized vials
• Laboratory testing services

Headquarters

HQ city

Jadra

HQ country

Lebanon

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sale of critical care medicines including cardiovascular, neuropsychiatry, gastroenterology, respiratory, antimicrobial, dermatology, hematology, endocrinology, pain management, anti-migraine, anti-inflammatory, anti-anemia, oncology, and emergency care products through distributor network

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Arwan Pharmaceutical Industries Lebanon develops, manufactures, and markets critical care pharmaceutical products across 18 therapeutic areas, including cardiovascular, neuropsychiatry, gastroenterology, respiratory, antimicrobial, dermatology, hematology, endocrinology, pain management, anti-migraine, anti-inflammatory, anti-anemia, oncology, and emergency care medicines. The company operates sterile injectable manufacturing lines producing liquid ampoules (2-5 mL), liquid vials (2 mL), and lyophilized vials (15-20 mL), and also provides WHO-prequalified quality control laboratory testing services. Products are sold through exclusive regional distributors across MENA, CIS, and Africa markets.

Product overview

Arwan Pharmaceutical Industries operates as a single unified pharmaceutical manufacturing and testing platform offering critical care medicines across 18 therapeutic areas including Cardiovascular Care, Neuropsychiatry, Gastroenterology & Hepatology, Respiratory Medicine, Antimicrobial Therapy, Dermatology, Hematology, Endocrinology & Metabolism, Pain & Inflammation Management, Anti-Migraine Therapy, Anti-Inflammatory Therapy, Anti-Anemia Therapy, Leukotriene Modifiers, Proton Pump Inhibitors, Gastrointestinal Motility Agents, Tissue Repair & Wound Healing, Oncology, and Critical & Emergency Care. The company manufactures sterile products including Liquid Ampoules (2-5 mL), Liquid Vials (2 mL), and Lyophilized Vials (15-20 mL) through versatile manufacturing lines. Additionally, Arwan provides WHO-prequalified laboratory testing services covering chemical analysis, microbiological testing, and quality control for regulated products.

Differentiator

Problem solved

Functional benefit

Products and services

• Liquid Ampoules Aseptic and terminal sterilization processes ensuring safety and sterility; liquid ampoules available in sizes from 2 mL to 5 mL for critical care pharmaceutical products.
• Liquid Vials Liquid vials in 2 mL capacities with aseptic filling processes that maintain the integrity and sterility of pharmaceutical products.
• Lyophilized Vials Lyophilized vials ranging from 15 mL to 20 mL, produced with advanced lyophilization technology to ensure stability and quality of pharmaceutical products.
• Laboratory Testing Services Quality control laboratory services including assay testing, dissolution, pH/conductivity, moisture determination, microbiological testing, sterility testing, and endotoxin testing. Offered through a WHO-prequalified laboratory (one of 57 worldwide, the only one in the Middle East), serving pharmaceutical companies and manufacturers requiring certified quality control testing.

Quantifiable outcome

• Serves over 17 countries globally
• +1 more outcomes

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

20 partnerships are on record, tiered core and minor.

• ABM4 ScientificcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Qatar market
• Delta PharmacycoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Oman market
• Adonis Drug StorecoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Jordan market
• AL SAIDALY Scientific BureaucoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Iraq market
• Al Sawah PharmacoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Kingdom of Saudi Arabia market
• Al Dabbous Medical CocoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Kuwait market
• Raymond Georges Abou Adal & Cie s.a.lcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Lebanon market
• Nooran Medical StorecoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in UAE market
• Rashid Omar Hijazi ltdcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Afghanistan market
• Tajikistan SinofarmacoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Tajikistan market
• Derman-Lukman GurallarycoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Turkmenistan market
• Crust Trading LPminorChannel Partner/ Reseller/ DistributorPartner distributor for Arwan pharmaceutical products in Turkmenistan market
• Global Pharm groupcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Uzbekistan market
• David Pharmaceutical IndustriescoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Botswana market
• New York Global Integrated Health Care (NYGIH)coreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Cameroon market
• Goodman Agencies LtdcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Kenya market
• Royale Resources Ltd Royale PharmaceuticalscoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Nigeria market
• Bio MisrcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Egypt market
• Almashafi Medical CompanycoreChannel Partner/ Reseller/ DistributorExclusive distributor for Arwan pharmaceutical products in Libya market
• European PartnerscoreStrategic or Co-development PartnerStrategic European partnerships providing access to advanced pharmaceutical manufacturing facilities and expertise

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hikma Pharmaceuticals: Jordan-headquartered specialty pharmaceutical manufacturer serving MENA and emerging markets across injectables, branded generics, and critical care products — directly comparable to Arwan's therapeutic breadth, emerging-market distribution model, and regional manufacturing strategy.
• Gulf Pharmaceutical Industries (Julphar): UAE-based pharmaceutical manufacturer producing generics and specialty medicines across multiple therapeutic categories for MENA markets — comparable in therapeutic breadth, regional focus, and distributor-led emerging-market go-to-market.
• Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO): Saudi Arabia's leading national pharma manufacturer producing branded generics across multiple therapeutic areas including cardiovascular and anti-infectives for MENA distribution — a comparable regional branded-generic manufacturer benefiting from local-content policies.
• Eva Pharma: Egypt-based pharmaceutical manufacturer with a broad critical care and specialty generics portfolio exported across MENA and Africa — overlapping therapeutic categories, distribution geographies, and WHO-aligned quality positioning.
• EIPICO: One of Egypt's largest pharmaceutical manufacturers producing a broad portfolio of generics across cardiovascular, anti-infectives, and critical care — comparable multi-therapeutic specialty generics manufacturer serving MENA and African markets.
• Tabuk Pharmaceuticals: Saudi pharmaceutical manufacturer with branded generics across cardiovascular, CNS, anti-infectives, and respiratory — comparable multi-therapeutic regional manufacturer benefiting from Saudi localization tailwinds.
• Pharco Pharmaceuticals: Egypt's largest branded-generic pharmaceutical manufacturer with broad therapeutic coverage and significant MENA/Africa export presence — directly comparable specialty generics peer serving overlapping emerging markets.

Broad incumbents

• Aspen Pharmacare: South Africa's largest pharma manufacturer with a global specialty/generics portfolio and emerging-market distribution across Africa and CIS — a much larger incumbent competing in similar regional tender and distribution channels.
• Cipla: Indian global pharmaceutical major with strong respiratory, anti-infective, and critical care portfolios plus significant emerging-market presence — a broad incumbent competing head-on in MENA/Africa tender bids Arwan targets.

Emerging players

• Strides Pharma Science: Indian specialty generics manufacturer focused on regulated and emerging markets with strength in sterile injectables and African distribution — comparable in emerging-market distributor-led model and injectable manufacturing focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php?id=61557921571961
• LinkedInlinkedin.com/company/arwan-pharma
• Instagraminstagram.com/arwanpharmaceuticalindustrie
• TikToktiktok.com/@arwanpharmaceutical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arwan Pharmaceutical Industries Lebanon